sponsored byAAAS Golden Fund

Username:

Password:

Register

Forgot Password?

Press Releases

Breaking News

Science Business

Grants, Awards, Books

Meetings

Multimedia

Science Agencies
on EurekAlert!

US Department of Energy

US National Institutes of Health

US National Science Foundation

Calendar

Submit a Calendar Item

Subscribe/Sponsor

Links & Resources

Portals

RSS Feeds

Accessibility Option On

Options

Portal Home

Glossary

Background Articles

Research Papers

Meetings

Links & Resources

Disease in the Developing World

News Releases

Key: Meeting M      Journal J      Funder F

Showing releases 151-175 out of 1343.

<< < 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 > >>

Public Release: 7-Dec-2016
Journal of Virology
Researchers combine MERS and rabies viruses to create innovative 2-for-1 vaccine
In a new study, researchers have modified a rabies virus, so that it has a protein from the MERS virus; this altered virus works as a 2-for-1 vaccine that protects mice against both Middle East Respiratory Syndrome (MERS) and rabies.

Contact: David Kohn
dkohn@som.umaryland.edu
410-706-7590
University of Maryland School of Medicine

Public Release: 7-Dec-2016
PLOS Neglected Tropical Diseases
Chemical mosquito controls ineffective in Zika fight
Some existing methods for controlling Zika-carrying mosquitoes are not effective and may even be counter-productive, according to research by scientists at the University of East Anglia (UEA). A review of previous studies into mosquito control interventions shows that there is a lack of clear evidence behind many of the strategies used to prevent the transmissions of insect-borne diseases like Zika virus, dengue and yellow fever.
RESPONSES Project, NIH/Research Health Protection Research Unit in Emergency Preparedness and Response, Public Health England

Contact: UEA Press Office
press@uea.ac.uk
44-016-035-93496
University of East Anglia

Public Release: 7-Dec-2016
68th Annual Conference of the Cardiological Society of India
Yoga reduces blood pressure in patients with prehypertension
Yoga reduces blood pressure in patients with prehypertension, according to a study presented at the 68th Annual Conference of the Cardiological Society of India (CSI).

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 7-Dec-2016
PLOS ONE
West African HIV-2 prevalence associated with lower historical male circumcision rates
In West African cities, male circumcision rates in 1950 were negatively correlated with HIV-2 prevalence from 1985, according to a study published Dec. 7, 2016 in the open-access journal PLOS ONE by João Sousa from the University of Leuven, Belgium, and colleagues.

Contact: Beth Jones
onepress@plos.org
PLOS

Public Release: 6-Dec-2016
Nature Communications
How our immune system targets TB
Researchers have seen, for the very first time, how the human immune system recognizes tuberculosis (TB). These findings are the crucial step in developing better diagnostics and perhaps even vaccines for this deadly infection.

Contact: Stephanie Pradier
stephanie.pradier@monash.edu
61-424-568-314
Monash University

Public Release: 6-Dec-2016
PLOS Pathogens
Raising the curtain on cerebral malaria's deadly agents
Using state-of-the-art brain imaging technology, scientists at the National Institutes of Health filmed what happens in the brains of mice that developed cerebral malaria (CM). The results, published in PLOS Pathogens, reveal the processes that lead to fatal outcomes of the disease and suggest an antibody therapy that may treat it.
NIH/Intramural Research Program

Contact: Barbara McMakin
nindspressteam@ninds.nih.gov
NIH/National Institute of Neurological Disorders and Stroke

Public Release: 6-Dec-2016
PLOS Pathogens
UTMB researchers find how Ebola disables the immune system
A new study at The University of Texas Medical Branch in Galveston sheds light on how Ebola so effectively disables the human immune system. Virologist Alex Bukreyev, UTMB professor and senior author of the study, said the research team engineered versions of the Ebola virus in order to study how the components responsible for thwarting or disabling our immune defenses wreak their havoc. The findings are described in the new edition of PLOS Pathogens.

Contact: Donna Ramirez
donna.ramirez@utmb.edu
409-772-8791
University of Texas Medical Branch at Galveston

Public Release: 6-Dec-2016
Research assesses impact of soil erosion on land and communities in East Africa
The impact of soil erosion on both the environmental and social well-being of communities in East Africa is to be explored in new research led by the University of Plymouth.
Global Challenges Research Fund, Natural Environment Research Council, Arts and Humanities Research Council, Economic and Social Research Council

Contact: Alan Williams
alan.williams@plymouth.ac.uk
44-175-258-8004
University of Plymouth

Public Release: 6-Dec-2016
JAMA Oncology
Cancer's deadly toll grows in less developed countries as new cases increase globally
While cancer is the world's second leading cause of death after cardiovascular diseases, the chances of getting cancer and dying from it look radically different depending on where you live, according to a new analysis of 32 cancer groups in 195 countries or territories.
Bill & Melinda Gates Foundation, National Institutes of Health

Contact: Kayla Albrecht
albrek7@uw.edu
206-897-3792
Institute for Health Metrics and Evaluation

Public Release: 5-Dec-2016
Journal of American Chemical Society
UMMS scientist designs lamp light operative photodynamic molecules for tumor therapy
UMass Medical School scientist Gang Han, PhD, and his team have designed a new class of molecules used in photodynamic therapy that are able to direct lamp light deep into tissue to kill cancer tumors.

Contact: Megan Bard
megan.bard@umassmed.edu
508-856-2296
University of Massachusetts Medical School

Public Release: 5-Dec-2016
IASLC 2016 World Conference on Lung Cancer
Global public health advocates open new fronts in war on tobacco
Efforts to control tobacco as a public health threat have escalated as clinicians and public health advocates have coalesced to beat back threats from tobacco companies through public advocacy, public health, and pension reform. Today, public health advocates from Brazil, Malaysia, Ireland, Australia, and Uruguay presented different strategies that have effectively reigned in the global threat of tobacco companies at a press briefing held at IASLC 17th World Conference on Lung Cancer (WCLC).

Contact: Chris Martin
cmartin@davidjamesgroup.com
630-670-2745
International Association for the Study of Lung Cancer

Public Release: 2-Dec-2016
The American Journal of Clinical Nutrition
Saturated fat could be good for you
A Norwegian study shows that saturated fat actually could be good for you. The quality of the food, whether it's highly processed or not, could have a larger impact on your health.

Contact: Simon E. Nitter Dankel
simon.dankel@uib.no
47-943-08637
The University of Bergen

Public Release: 1-Dec-2016
Monell Center receives grant to develop technologies to improve taste of lifesaving drugs
The Monell Center announced today that it has received a $345,000 grant from the Bill & Melinda Gates Foundation. The grant supports an innovative global health research project titled, 'Developing Novel Pediatric Formulation Technologies for Global Health: Human Taste Assays.'
Bill & Melinda Gates Foundation

Contact: Leslie Stein
stein@monell.org
267-519-4707
Monell Chemical Senses Center

Public Release: 1-Dec-2016
PLOS Neglected Tropical Diseases
Test created in Brazil can diagnose 416 viruses from tropical regions
Researchers from the University of São Paulo (USP) in Brazil have developed a platform that analyzes clinical samples from patients to diagnose infection by 416 viruses found in the world's tropical regions. The tool can be used to assist epidemiological surveillance by detecting pathogens with the potential to cause epidemics in humans.
São Paulo Research Foundation

Contact: Samuel Antenor
samuel@fapesp.br
55-113-838-4381
Fundação de Amparo à Pesquisa do Estado de São Paulo

Public Release: 1-Dec-2016
Findings show significant progress against HIV epidemic in Africa; 90-90-90 goals in reach
National surveys in Zimbabwe, Malawi, and Zambia reveal exceptional progress against HIV, with decreasing rates of new infection, stable numbers of people living with HIV, and more than half of all those living with HIV showing viral suppression through use of antiretroviral medication. For those on antiretroviral medication, viral suppression is close to 90 percent. Thirty-five years into the global HIV epidemic, these findings are a clear sign of progress and source of hope for the rest of the world.
US President's Emergency Plan for AIDS Relief, US Centers for Disease Control and Prevention

Contact: Stephanie Berger
sb2247@columbia.edu
212-305-4372
Columbia University's Mailman School of Public Health

Public Release: 1-Dec-2016
New England Journal of Medicine
IPM's ring study results published in New England Journal of Medicine
IPM announced today that the New England Journal of Medicine has published results from the Ring Study, a Phase III clinical trial of IPM's vaginal ring to prevent HIV. Also see NEJM's short video summary. The study's key findings, announced earlier this year, show that a vaginal ring that slowly releases the antiretroviral drug (ARV) dapivirine over the course of one month safely helps reduce the risk of HIV infection in women.

Contact: Holly Seltzer
hseltzer@IPMglobal.org
301-608-4277
International Partnership for Microbicides (IPM)

Public Release: 1-Dec-2016
Cell Stem Cell
How Zika infects the growing brain
Studies have suggested that Zika enters neural progenitor cells by grabbing onto a specific protein called AXL on the cell surface. Now, scientists at the Harvard Stem Cell Institute and Novartis have shown that this is not the only route of infection. The scientists demonstrated that Zika infected neural progenitor cells even when the cells did not produce the AXL surface protein that is widely thought to be the main vehicle of entry for the virus.
The Stanley Center for Psychiatric Research, Harvard Stem Cell Institute

Contact: David Cameron
david_cameron@harvard.edu
617-495-2931
Harvard University

Public Release: 1-Dec-2016
PLOS Neglected Tropical Diseases
Unique strains of Brazilian leishmaniasis set apart by genetics
Some of the roughly 1 million cases a year of the parasitic disease leishmaniasis don't fit with the standard definition of the disease -- the patients have unusual symptoms and front-line medicines don't work. Now, researchers have discovered why many of these cases are so different -- they're caused by parasites with distinct genetic variations. The finding, reported in PLOS Neglected Tropical Diseases, was made by studying patients in northeast Brazil but may hold true elsewhere around the world.

Contact: PLOS Neglected Tropical Diseases
plosntds@plos.org
PLOS

Public Release: 30-Nov-2016
PLOS ONE
Benefits of daily aspirin outweigh risk to stomach
Stomach bleeds caused by aspirin are considerably less serious than the spontaneous bleeds that can occur in people not taking the drug, concludes a study led by Cardiff University.

Contact: Julia Short
ShortJ4@cardiff.ac.uk
44-029-208-75596
Cardiff University

Public Release: 30-Nov-2016
Ophthalmology
Zika and glaucoma linked for first time in new study
A team of researchers in Brazil and at the Yale School of Public Health has published the first report demonstrating that the Zika virus can cause glaucoma in infants who were exposed to the virus during gestation.

Contact: Michael Greenwood
michael.greenwood@yale.edu
203-737-5151
Yale University

Public Release: 30-Nov-2016
PLOS Medicine
Vital vaccine could 'reduce burden' of dengue disease in hardest-hit regions
A team of international researchers, including Dr. Mario Recker from the University of Exeter, have looked at the impact and cost-effectiveness of the vaccine, called Dengvaxia, under a host of varying conditions.
World Health Organization, Gavi, The Vaccine Alliance, University of Western Australia, Royal Society University Research Fellowship, UK Medical Research Council, National Institute for Health Research, NIH/National Institute of General Medical Sciences

Contact: Duncan Sandes
D.Sandes@exeter.ac.uk
01-392-722-391
University of Exeter

Public Release: 30-Nov-2016
2016 Royal Australian Chemical Institute Organic One Day Symposium
Breaking good: School students make costly drug cheaply using open source approach
High school students under University of Sydney guidance have shown how simple it is to make a version of the life-saving medicine Daraprim, whose price was the subject of controversy last year when it jumped more than 5,000 percent.

Contact: Vivienne Reiner
vivienne.reiner@sydney.edu.au
61-293-512-390
University of Sydney

Public Release: 30-Nov-2016
Lancet Infectious Diseases
HIV patients showing signs of multidrug resistance in Africa
Significant numbers of patients whose HIV strains developed resistance to older generation drugs are also resistant to modern drugs, finds a new study led by UCL (University College London) and funded by Wellcome. The research, co-authored by researchers at the London School of Hygiene and Tropical Medicine and published in The Lancet Infectious Diseases, studied 712 HIV patients across the world whose HIV was not controlled by antiretrovirals.
Wellcome

Contact: Harry Dayantis
h.dayantis@ucl.ac.uk
44-203-108-3844
University College London

Public Release: 30-Nov-2016
Nature Communications
A method for storing vaccines at room temperature
Several simple and inexpensive techniques make it possible to store antiviral-vaccines at room temperature for several months. This discovery by EPFL researchers and partners could make a difference in inaccessible areas and developing countries where maintaining cold-chain transportation of vaccines is complicated and expensive.

Contact: Francesco Stellacci
francesco.stellacci@epfl.ch
41-216-937-872
Ecole Polytechnique Fédérale de Lausanne

Public Release: 29-Nov-2016
PLOS Medicine
Dengue vaccine estimated to reduce disease burden in dengue-affected areas
The first available dengue vaccine, CYD-TDV (Dengvaxia), is estimated to reduce the burden of dengue and be potentially cost effective in settings where infections with dengue are common, according to a study published by Stefan Flasche from the London School of Hygiene & Tropical Medicine, UK and an international consortium of dengue experts, in PLOS Medicine.

Contact: Stefan Flasche
Stefan.Flasche@lshtm.ac.uk
PLOS

Showing releases 151-175 out of 1343.

<< < 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 > >>